SOUTH SAN FRANCISCO, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation, a leader in mass cytometry and microfluidics technologies, today announced a new bimodal single‑cell application ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Fluidigm Corporation (NAS: FLDM) announced that its C 1 ™ Single-Cell Auto Prep system Early Access Program (EAP) has concluded. The EAP originally ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Fluidigm Corporation (NAS: FLDM) today introduced the mRNA sequencing application on its C1™ Single-Cell Auto Prep System. With this new C1 system ...

Developer and seller of microfluidic systems, Fluidigm Corp ( FLDM) recently announced a new single-cell application for its C1 system, which improves whole genome sequencing of individual cells.

Fluidigm Corp. FLDM recently announced the availability of Single-Cell ATAC-seq, an epigenetics application, for the C1 system. The application is also available on Script Hub - a new web portal ...

To Gain a Systems Perspective, Explore the Genomic Heterogeneity of Cell Populations Fluidigm, a pioneer of single-cell biology, has announced a new technology that enables individual cells to be ...

Callisto is designed to seamlessly integrate into Fluidigm’s portfolio of genomics and proteomics products. Scientists will be able to harvest single-cell suspensions or bulk culture samples from ...

The new technologies enable the advancement of nucleic acid research methods and open up new areas of biological enquiry for the Institute and wider science community. Providing researchers with ...

The Genome Institute of Singapore (GIS) and Fluidigm say they have established the first research center in Asia exclusively dedicated to accelerating the understanding of how individual cells work, ...

WASHINGTON--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ: FLDM) announced a new workflow that enables high throughput single-cell mRNA sequencing. This workflow, which was presented today at the ...